Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000531192 | SCV000624311 | benign | Primary ciliary dyskinesia | 2025-01-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000531192 | SCV002687607 | uncertain significance | Primary ciliary dyskinesia | 2015-09-03 | criteria provided, single submitter | clinical testing | The p.R3077Q variant (also known as c.9230G>A), located in coding exon 55 of the DNAH5 gene, results from a G to A substitution at nucleotide position 9230. The arginine at codon 3077 is replaced by glutamine, an amino acid with highly similar properties. This variant was previously reported in the SNPDatabase as rs113742238. Based on data from the NHLBI Exome Sequencing Project (ESP), the A allele has an overall frequency of approximately 0.03% (4/13006) total alleles studied, having been observed in 0.07% (3/4406) African American alleles and 0.01% (1/8600) European American alleles. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. |
Breakthrough Genomics, |
RCV004691841 | SCV005189420 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000531192 | SCV001452464 | uncertain significance | Primary ciliary dyskinesia | 2019-10-28 | no assertion criteria provided | clinical testing |